ABBV vs MRK: Stock Comparison

AbbVie Inc. (ABBV) and Merck & Company, Inc. Common Stock (new) (MRK) compared side by side on 20 fundamental metrics — valuation, profitability, growth, balance sheet, and returns. Live data, updated hourly.

ABBV trades at the lower earnings multiple (80.21x vs 118.05x), while MRK has the higher return on equity (6.60% vs -136.50%).

Metric ABBV MRK
Stock Price $285.64 $145.27
Market Cap $504.8B $358.4B
P/E Ratio 80.21 118.05
P/B Ratio -84.96 8.77
P/S Ratio 7.81 5.53
EV/EBITDA 26.78 29.93
PEG Ratio 1.18 -1.46
Return on Equity -136.50% 6.60%
ROCE 20.19% 10.83%
Return on Assets 4.67% 2.44%
Gross Margin 71.48% 75.38%
Net Margin 9.81% 4.78%
Revenue Growth (1y) +8.57% +1.18%
Profit Growth (1y) -1.22% +6.64%
Debt / Equity -11.93 1.29
Current Ratio 0.81 1.32
Interest Coverage 6.47 8.75
Dividend Yield 2.43% 2.29%
Beta 0.28 0.23
1-Year Return +28.89% +71.53%

Green bold marks the higher value on each metric, or the lower value for valuation multiples and debt-to-equity. It shows direction only and is not a ranking of either stock: sector norms, one-off items and growth stage all affect how a number reads. Not investment advice.

Full ABBV data →  ·  Full MRK data →  ·  Screen 4,900+ stocks →

More Comparisons

All 60 stock comparisons →